Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D09CGL
|
|||
| Former ID |
DNC000514
|
|||
| Drug Name |
Daio-Orengedokuto (DOT)
|
|||
| Synonyms |
26159-34-2; Miranax; Naproxen sodium salt; Synflex; Naprodol; Naprodil; Leniartril; Gibixen; Floxalin; Flogogin; Aprowell; Anapran; Primeral; Pactens; Naprovite; Gibinap; Floneks; Anaprotab; Monarit; Karoksen; Sodimax; Natrioxen; Floginex; Opraks; Kapnax; Tandax; Flogen; Nixal; Aprol; Naprux Gesic; Causalon Pro; Naproxen natrium; Axer Alfa; Dysmenalgit; Veradol; Naprium; Diocodal; Proxen; Prexan; Naprux; A-Nox; Xenar; Laser; Apo-Napro-NA; UNII-9TN87S3A3C; sodium na
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C14H13NaO3
|
|||
| Canonical SMILES |
CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)[O-].[Na+]
|
|||
| InChI |
1S/C14H14O3.Na/c1-9(14(15)16)10-3-4-12-8-13(17-2)6-5-11(12)7-10;/h3-9H,1-2H3,(H,15,16);/q;+1/p-1/t9-;/m0./s1
|
|||
| InChIKey |
CDBRNDSHEYLDJV-FVGYRXGTSA-M
|
|||
| CAS Number |
CAS 26159-34-2
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
855887, 7848033, 11112047, 11113013, 16497863, 16652751, 17405353, 24278533, 24897724, 46242366, 46386948, 49703461, 49995359, 50106619, 53777898, 56045041, 56422873, 57387508, 57654352, 76649075, 81067403, 85231338, 91615091, 92125888, 92304158, 92308602, 93581324, 103770789, 103811615, 103914414, 104178969, 104253263, 117374972, 118843738, 121361730, 124659066, 124757385, 124799356, 125164189, 131307788, 134338791, 134339923, 134998265, 135692197, 135697872, 136946681, 137022154, 143491403, 144089136, 144116265
|
|||
| ChEBI ID |
CHEBI:7477
|
|||
| SuperDrug ATC ID |
G02CC02
|
|||
| SuperDrug CAS ID |
cas=022204531
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Pancreatic triacylglycerol lipase (PNLIP) | Target Info | Inhibitor | [1] |
| BioCyc | Triacylglycerol degradation | |||
| Retinol biosynthesis | ||||
| KEGG Pathway | Glycerolipid metabolism | |||
| Metabolic pathways | ||||
| Pancreatic secretion | ||||
| Fat digestion and absorption | ||||
| Vitamin digestion and absorption | ||||
| Reactome | Retinoid metabolism and transport | |||
| WikiPathways | Visual phototransduction | |||
| Lipid digestion, mobilization, and transport | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Daio-Orengedokuto inhibits HMG-CoA reductase and pancreatic lipase. Biol Pharm Bull. 2002 Nov;25(11):1442-5. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.